Eastern Bank’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2K | Sell |
436
-16
| -4% | -$1.33K | ﹤0.01% | 596 |
|
|
2025
Q1 | $36.7K | Sell |
452
-21
| -4% | -$1.7K | ﹤0.01% | 588 |
|
|
2024
Q4 | $42.6K | Sell |
473
-114
| -19% | -$10.3K | ﹤0.01% | 588 |
|
|
2024
Q3 | $58K | Buy |
+587
| New | +$58K | ﹤0.01% | 543 |
|
|
2024
Q1 | – | Sell |
-4,343
| Closed | -$388K | – | 213 |
|
|
2023
Q4 | $388K | Sell |
4,343
-134,878
| -97% | -$12M | 0.02% | 169 |
|
|
2023
Q3 | $10.2M | Sell |
139,221
-45
| -0% | -$3.29K | 0.51% | 69 |
|
|
2023
Q2 | $11.6M | Buy |
139,266
+623
| +0.4% | +$51.8K | 0.55% | 68 |
|
|
2023
Q1 | $10.6M | Buy |
+138,643
| New | +$10.6M | 0.53% | 71 |
|
|
2022
Q1 | – | Sell |
-7,079
| Closed | -$793K | – | 209 |
|
|
2021
Q4 | $793K | Sell |
7,079
-5,257
| -43% | -$589K | 0.03% | 146 |
|
|
2021
Q3 | $1.55M | Sell |
12,336
-2,920
| -19% | -$367K | 0.07% | 112 |
|
|
2021
Q2 | $2.07M | Sell |
15,256
-175,330
| -92% | -$23.7M | 0.1% | 108 |
|
|
2021
Q1 | $25.9M | Sell |
190,586
-26,379
| -12% | -$3.58M | 1.4% | 20 |
|
|
2020
Q4 | $30.5M | Sell |
216,965
-10,689
| -5% | -$1.5M | 1.71% | 11 |
|
|
2020
Q3 | $25.4M | Sell |
227,654
-5,557
| -2% | -$619K | 1.55% | 13 |
|
|
2020
Q2 | $26.1M | Sell |
233,211
-9,589
| -4% | -$1.07M | 1.7% | 12 |
|
|
2020
Q1 | $18.8M | Sell |
242,800
-8,533
| -3% | -$661K | 1.4% | 17 |
|
|
2019
Q4 | $23.9M | Buy |
251,333
+7,386
| +3% | +$702K | 1.39% | 18 |
|
|
2019
Q3 | $18.6M | Buy |
243,947
+5,417
| +2% | +$413K | 1.16% | 27 |
|
|
2019
Q2 | $20.9M | Buy |
238,530
+8,857
| +4% | +$777K | 1.33% | 18 |
|
|
2019
Q1 | $20.8M | Sell |
229,673
-3,062
| -1% | -$277K | 1.39% | 17 |
|
|
2018
Q4 | $16.7M | Buy |
+232,735
| New | +$16.7M | 1.25% | 24 |
|